It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: Rich Z
Just out of curiosity, what animals ARE now at the top of that list?
Biopharmaceutical company Medicago and drug maker GlaxoSmithKline reported Tuesday positive efficacy and safety results from the Phase 3 trial of their plant-based COVID-19 vaccine.
Medicago, which is headquartered in Quebec, reported in a news release that their Phase 3 placebo-controlled study -- conducted in more than 24,000 subjects in six countries who are 18 and older -- reported an overall vaccine efficacy rate of 71 per cent against all variants of SARS-CoV-2 which were circulating at the time of the study.
“Vaccine efficacy was demonstrated in an environment dominated by SARS-CoV-2 variants unlike most published Phase 3 efficacy trials for currently licensed COVID-19 vaccines that were conducted when only the ancestral virus was circulating,” the release states.
Additionally, there is an insertion at position 214 which adds three amino acids to the genome. Some have speculated that this insertion is related to recombination with human cold-causing coronaviruses, specifically HCoV-229E. We offer a more likely alternative, suggested by Dr. Roberto Patarca, which is that the change is potentially due to internal recombination and translocation of a segment in the (-) strand of the 5’-untranslated region (UTR) of SARS-CoV-2 that would also explain other insertions at the same position 214. We note that this is a frequent site for insertions in other viruses.
In our previous article on Omicron’s possible origins, we noted the potential of cross-species infection of SARS-CoV-2 resulting in new and aggressive mutations. One study by Johnson et al. revealed dozens of mutations found in wastewater samples likely originating from rats or dogs. Several mutations found in those samples are in positions mutated in Omicron, including K417N, N440K, S477N, E484A, G496S, Q498R, N501Y, and others. This mass overlap may indicate that Omicron may have formed some or all of its mutations in a non-human animal before reinfecting human populations in Africa.
In a tweet published this Thursday, December 9, the IHU Méditerranée infection, headed by Professor Didier Raoult, announces that it has discovered a new variant of Covid-19. For the moment, no additional information has been given.
"It was baptized variant IHU and deposited on GISAID (scientific sharing network, Editor's note) under the name of B.1.640.2." details the establishment in its tweet. To date, no additional information on this variant has been brought to our attention.